Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell

Shih Hwa Chiou, Shih Jen Chen, Chi Hsien Peng, Yu Li Chang, Hung Hai Ku, Wen-Ming Hsu, Larry L.T. Ho, Chen Hsen Lee

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Fluoxetine is a widely used antidepressant compound which inhibits the reuptake of serotonin in the central nervous system. Recent studies have shown that fluoxetine can promote neurogenesis and improve the survival rate of neurons. However, whether fluoxetine modulates the proliferation or neuroprotection effects of neural stem cells (NSCs) needs to be elucidated. In this study, we demonstrated that 20 μM fluoxetine can increase the cell proliferation of NSCs derived from the hippocampus of adult rats by MTT test. The up-regulated expression of Bcl-2, Bcl-xL and the cellular FLICE-inhibitory protein (c-FLIP) in fluoxetine-treated NSCs was detected by real-time RT-PCR. Our results further showed that fluoxetine protects the lipopolysaccharide- induced apoptosis in NSCs, in part, by activating the expression of c-FLIP. Moreover, c-FLIP induction by fluoxetine requires the activation of the c-FLIP promoter region spanning nucleotides -414 to -133, including CREB and SP1 sites. This effect appeared to involve the phosphatidylinositol-3-kinase-dependent pathway. Furthermore, fluoxetine treatment significantly inhibited the induction of proinflammatory factor IL-1β, IL-6, and TNF-α in the culture medium of LPS-treated NSCs (p < 0.01). The results of high performance liquid chromatography coupled to electrochemical detection further confirmed that fluoxentine increased the functional production of serotonin in NSCs. Together, these data demonstrate the specific activation of c-FLIP by fluoxetine and indicate the novel role of fluoxetine for neuroprotection in the treatment of depression.

Original languageEnglish
Pages (from-to)391-400
Number of pages10
JournalBiochemical and Biophysical Research Communications
Volume343
Issue number2
DOIs
Publication statusPublished - May 5 2006
Externally publishedYes

Fingerprint

CASP8 and FADD-Like Apoptosis Regulating Protein
Neural Stem Cells
Fluoxetine
Stem cells
Hippocampus
Up-Regulation
Apoptosis
Serotonin
Chemical activation
Phosphatidylinositol 3-Kinase
Neurogenesis
Cell proliferation
High performance liquid chromatography
Neurology
Interleukin-1
Genetic Promoter Regions
Antidepressive Agents
Neurons
Culture Media
Lipopolysaccharides

Keywords

  • Cellular FLICE-inhibitory protein
  • Fluoxetine
  • Lipopolysaccharide
  • Neural stem cells

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. / Chiou, Shih Hwa; Chen, Shih Jen; Peng, Chi Hsien; Chang, Yu Li; Ku, Hung Hai; Hsu, Wen-Ming; Ho, Larry L.T.; Lee, Chen Hsen.

In: Biochemical and Biophysical Research Communications, Vol. 343, No. 2, 05.05.2006, p. 391-400.

Research output: Contribution to journalArticle

Chiou, Shih Hwa ; Chen, Shih Jen ; Peng, Chi Hsien ; Chang, Yu Li ; Ku, Hung Hai ; Hsu, Wen-Ming ; Ho, Larry L.T. ; Lee, Chen Hsen. / Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 343, No. 2. pp. 391-400.
@article{d471e287c403419993ba0cedad054fc1,
title = "Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell",
abstract = "Fluoxetine is a widely used antidepressant compound which inhibits the reuptake of serotonin in the central nervous system. Recent studies have shown that fluoxetine can promote neurogenesis and improve the survival rate of neurons. However, whether fluoxetine modulates the proliferation or neuroprotection effects of neural stem cells (NSCs) needs to be elucidated. In this study, we demonstrated that 20 μM fluoxetine can increase the cell proliferation of NSCs derived from the hippocampus of adult rats by MTT test. The up-regulated expression of Bcl-2, Bcl-xL and the cellular FLICE-inhibitory protein (c-FLIP) in fluoxetine-treated NSCs was detected by real-time RT-PCR. Our results further showed that fluoxetine protects the lipopolysaccharide- induced apoptosis in NSCs, in part, by activating the expression of c-FLIP. Moreover, c-FLIP induction by fluoxetine requires the activation of the c-FLIP promoter region spanning nucleotides -414 to -133, including CREB and SP1 sites. This effect appeared to involve the phosphatidylinositol-3-kinase-dependent pathway. Furthermore, fluoxetine treatment significantly inhibited the induction of proinflammatory factor IL-1β, IL-6, and TNF-α in the culture medium of LPS-treated NSCs (p < 0.01). The results of high performance liquid chromatography coupled to electrochemical detection further confirmed that fluoxentine increased the functional production of serotonin in NSCs. Together, these data demonstrate the specific activation of c-FLIP by fluoxetine and indicate the novel role of fluoxetine for neuroprotection in the treatment of depression.",
keywords = "Cellular FLICE-inhibitory protein, Fluoxetine, Lipopolysaccharide, Neural stem cells",
author = "Chiou, {Shih Hwa} and Chen, {Shih Jen} and Peng, {Chi Hsien} and Chang, {Yu Li} and Ku, {Hung Hai} and Wen-Ming Hsu and Ho, {Larry L.T.} and Lee, {Chen Hsen}",
year = "2006",
month = "5",
day = "5",
doi = "10.1016/j.bbrc.2006.02.180",
language = "English",
volume = "343",
pages = "391--400",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell

AU - Chiou, Shih Hwa

AU - Chen, Shih Jen

AU - Peng, Chi Hsien

AU - Chang, Yu Li

AU - Ku, Hung Hai

AU - Hsu, Wen-Ming

AU - Ho, Larry L.T.

AU - Lee, Chen Hsen

PY - 2006/5/5

Y1 - 2006/5/5

N2 - Fluoxetine is a widely used antidepressant compound which inhibits the reuptake of serotonin in the central nervous system. Recent studies have shown that fluoxetine can promote neurogenesis and improve the survival rate of neurons. However, whether fluoxetine modulates the proliferation or neuroprotection effects of neural stem cells (NSCs) needs to be elucidated. In this study, we demonstrated that 20 μM fluoxetine can increase the cell proliferation of NSCs derived from the hippocampus of adult rats by MTT test. The up-regulated expression of Bcl-2, Bcl-xL and the cellular FLICE-inhibitory protein (c-FLIP) in fluoxetine-treated NSCs was detected by real-time RT-PCR. Our results further showed that fluoxetine protects the lipopolysaccharide- induced apoptosis in NSCs, in part, by activating the expression of c-FLIP. Moreover, c-FLIP induction by fluoxetine requires the activation of the c-FLIP promoter region spanning nucleotides -414 to -133, including CREB and SP1 sites. This effect appeared to involve the phosphatidylinositol-3-kinase-dependent pathway. Furthermore, fluoxetine treatment significantly inhibited the induction of proinflammatory factor IL-1β, IL-6, and TNF-α in the culture medium of LPS-treated NSCs (p < 0.01). The results of high performance liquid chromatography coupled to electrochemical detection further confirmed that fluoxentine increased the functional production of serotonin in NSCs. Together, these data demonstrate the specific activation of c-FLIP by fluoxetine and indicate the novel role of fluoxetine for neuroprotection in the treatment of depression.

AB - Fluoxetine is a widely used antidepressant compound which inhibits the reuptake of serotonin in the central nervous system. Recent studies have shown that fluoxetine can promote neurogenesis and improve the survival rate of neurons. However, whether fluoxetine modulates the proliferation or neuroprotection effects of neural stem cells (NSCs) needs to be elucidated. In this study, we demonstrated that 20 μM fluoxetine can increase the cell proliferation of NSCs derived from the hippocampus of adult rats by MTT test. The up-regulated expression of Bcl-2, Bcl-xL and the cellular FLICE-inhibitory protein (c-FLIP) in fluoxetine-treated NSCs was detected by real-time RT-PCR. Our results further showed that fluoxetine protects the lipopolysaccharide- induced apoptosis in NSCs, in part, by activating the expression of c-FLIP. Moreover, c-FLIP induction by fluoxetine requires the activation of the c-FLIP promoter region spanning nucleotides -414 to -133, including CREB and SP1 sites. This effect appeared to involve the phosphatidylinositol-3-kinase-dependent pathway. Furthermore, fluoxetine treatment significantly inhibited the induction of proinflammatory factor IL-1β, IL-6, and TNF-α in the culture medium of LPS-treated NSCs (p < 0.01). The results of high performance liquid chromatography coupled to electrochemical detection further confirmed that fluoxentine increased the functional production of serotonin in NSCs. Together, these data demonstrate the specific activation of c-FLIP by fluoxetine and indicate the novel role of fluoxetine for neuroprotection in the treatment of depression.

KW - Cellular FLICE-inhibitory protein

KW - Fluoxetine

KW - Lipopolysaccharide

KW - Neural stem cells

UR - http://www.scopus.com/inward/record.url?scp=33645120961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645120961&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.02.180

DO - 10.1016/j.bbrc.2006.02.180

M3 - Article

VL - 343

SP - 391

EP - 400

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -